Recent studies have demonstrated that S100A10 interacts with annexin A2 (ANXA2) to activate the mTOR pathway, thereby promoting tumor glycolysis and driving malignant tumor progression (Li et al., 2020). Here, S100A10 is linked to neoplasm.